Philip Joseph

A session on “Polypill and Fixed Dose Combination Strategies: How to Act upon the Accumulated Evidence” will be held at the 19th Global Cardiovascular Clinical Trialists (CVCT) Forum in Washington, DC on December 1, 2022, 4:00 – 6:00 pm ET.

Chaired by PHRI’s Executive Director, Salim Yusuf, and PHRI Senior International Fellow Clara Chow, the session will include:

  • History of the polypill and its essential role in global CVD prevention: Salim Yusuf
  • The evidence so far: Summary of trials of the polypill in primary prevention: Philip Joseph, PHRI Investigator
  • Summary of trials of the polypill in secondary prevention: Jose Castellano (Madrid, ESP)
  • Statistical viewpoint: Jan Tijssen (Narrden, NED)

Andre Lamy

  • Cost effectiveness of the polypill: PHRI Scientist André Lamy
  • Potential global Impact of the polypill and role of the polypill in achieving the UN Sustainable Development Goals 2030 goals: Tom Gaziano (Boston, USA)
  • Can fixed dose combination improve adherence and prevent unnecessary deaths from cardiovascular disease?: Clara Chow (Sydney, AUS)
  • World Heart Federation strategy for advocacy of the polypills/FDC for global CVD prevention: Fausto Pinto (Lisbon, PRT)
  • Would polypills help with heart failure therapy implementation?: Ambarish Pandey (Dallas, TX, USA)
  • Industry viewpoint: Roberto Álvarez (Ferrer, ESP), Samuele Doratori (Servier, FRA)
  • Polypill and fixed dose combination approvability issues: Rosalyn Adigun (FDA, USA)
  • Patient’s viewpoint: Steve Macari (Poitiers, FRA)
  • Panelists will also include: Rahul Agrawal (Cardior, CHE); Tomas Andersson (AstraZeneca, SWE), Guiomar Mendieta Badimon (CVCT Future trialist, Madrid, ESP); Issa Dahabreh (Boston, USA); Patrice Desvigne-Nickens (NHLBI, USA), Joao Ferreira (Porto, PRT), Lawrence Fine (NHLBI, USA); Lars Johansson (Antaros, SWE); Matthew Lee (CVCT Future trialist, Glasgow, UK); Ciaran McMullan (Merck, USA); Reza Mohebi (Boston, USA), Pieter Muntendam (G3P, USA); Ambarish Pandey (Dallas, TX, USA); Paul Ridker (Boston, MA, USA), Robert Temple (FDA, USA), Jan Tijssen (Narrden, NED), Faiez Zannad (Paris, FRA).
Clara Chow and Salim Yusuf 2022

The “Polypill and Fixed Dose Combination Strategies’ session at CVCT Global Forum 2022 will be co-chaired by Clara Chow and Salim Yusuf (shown here at PHRI offices in Hamilton, Canada in September 2022).

Back To Top